Evry
France
31
2025-02-06
17
2024-12-24
These are the the leading inventors for applications assigned to Universite D'Evry Val D'Essonne:
Universite D'Evry Val D'Essonne based in Evry, FR has been assigned the rights to these inventions. The list includes both Pending Applications and Patent Grants:
Gene Therapy of Fibroblast Growth Factor 23 Related Hypophosphatemic Diseases
#2 | 2024-09-26Hybrid Recombinant Adeno-Associated Virus Serotype Between AAV9 and AAVrh74 with Reduced Liver Tropism
#3 | 2024-06-27Peptide-Modified AAV Capsid
#4 | 2023-09-07Treatment of Dilated Cardiomyopathies
#5 | 2023-08-31Enhancing Utrophin Expression in Cell by Inducing Mutations Within Utrophin Regulatory Elements and Therapeutic Use Thereof
#6 | 2023-08-24Treatment of Genetic Dilated Cardiomyopathies
#7 | 2023-08-10NRF2 Activator for Use in Treating Dilated Cardiomyopathies
#8 | 2023-08-03Method for Engineering Novel Hybrid AAV Capsids Through Hyper Variable Regions Swapping
#9 | 2023-07-13CILP-1 Inhibitors for Use in the Treatment of Dilated Cardiomyopathies
#10 | 2022-09-08New Adeno-Associated Virus (AAV) Variants and Uses Thereof for Gene Therapy
#11 | 2022-07-21Peptide-Modified Hybrid Recombinant Adeno-Associated Virus Serotype Between AAV9 and AAVrh74 with Reduced Liver Tropism and Increased Muscle Transduction
#12 | 2021-11-11 ✅ Patent 12,171,843 granted on 2024-12-24Hybrid regulatory elements
#13 | 2021-11-04 ✅ Patent 11,596,698 granted on 2023-03-07Synthetic polynucleotides encoding a human FKRP protein
#14 | 2021-07-22 ✅ Patent 12,195,368 granted on 2025-01-14Method for decontaminating heavy metals in an aqueous solution
#15 | 2021-07-01Use of Syncytin for Targeting Drug and Gene Delivery to Lung Tissue
#16 | 2021-05-06 ✅ Patent 11,427,836 granted on 2022-08-30Method for reducing the expression of NKCC1 in a subject
#17 | 2021-04-15 ✅ Patent 12,037,362 granted on 2024-07-16Hybrid recombinant adeno-associated virus serotype between AAV9 and AAVrh74 with reduced liver tropism
#18 | 2021-04-01 ✅ Patent 11,499,154 granted on 2022-11-15Antisense targeting dynamin 2 and use for the treatment of centronuclear myopathies and neuropathies
#19 | 2021-03-04 ✅ Patent 11,298,348 granted on 2022-04-12Combination treatment of sarcoglycanopathies
#20 | 2020-09-17 ✅ Patent 11,541,131 granted on 2023-01-03Treatment of glycogen storage disease III
#21 | 2020-08-20Use of a Syncytin for Targeting Drug and Gene Delivery to Regenerate Muscle Tissue
#22 | 2020-07-02 ✅ Patent 11,466,298 granted on 2022-10-11Method for preparing phosphorylated keto polyols, derivatives thereof and uses thereof
#23 | 2019-12-26 ✅ Patent 11,339,406 granted on 2022-05-24Acid-alpha glucosidase variants and uses thereof
#24 | 2018-11-08 ✅ Patent 11,371,061 granted on 2022-06-28Compositions and methods for improving viral vector efficiency
#25 | 2018-04-12 ✅ Patent 11,104,897 granted on 2021-08-31Compositions and methods for the treatment of nucleotide repeat expansion disorders
#26 | 2017-10-26 ✅ Patent 10,654,838 granted on 2020-05-19Aminopyridine compounds useful as inhibitors of protein prenylation
#27 | 2017-02-16 ✅ Patent 9,777,272 granted on 2017-10-03Methods for the treatment of Leber congenital amaurosis
#28 | 2016-12-29 ✅ Patent 11,754,561 granted on 2023-09-12Functionalized biochips for SPR-MS coupling
#29 | 2015-04-23 ✅ Patent 9,487,782 granted on 2016-11-08Methods for the treatment of leber congenital amaurosis
#30 | 2013-07-04CALPAIN-3 INHIBITORS FOR TREATING MUSCULAR DYSTROPHIES AND CARDIOMYOPATHIES
#31 | 2011-04-21 ✅ Patent 8,658,150 granted on 2014-02-25Polymer derived from linear polyethylenimine for gene transfer
Also check out UNIVERSITE D'EVRY-VAL-D'ESSONNE's (Evry, France) applicant profile with 20 patent applications submitted.
28907 ⎘